8 June, 2023 | Online
Chairs: Prof. Dr Christoph Lange (Borstel, Germany); Prof. Dr Raquel Duarte (Porto, Portugal)
Speakers: Prof. Stephen Henry Gillespie (St. Andrews, United Kingdom), Mr. Niklas Köhler (Lübeck, Germany), Ms. Jodie Schildkraut (Nijmegen, Netherlands)
Overall, the aim is to enhance participants' knowledge of biomarkers, surrogate markers, and treatment monitoring tools for tuberculosis clinical trials, with a view to improving diagnosis and treatment outcomes.
Webinar will be divided into 2 parts (of approximately 30 mins. each):
? For the first 30 minutes, the speaker Stephen Gillespie will debate the pros and cons of rolling out new drugs and treatment regimens for TB without diagnostic capacities.
? The second half of the webinar will be filled with an open discussion, moderated by Raquel Duarte and Christoph Lange, giving the opportunity to the participants of sharing perspectives on the topics presented and/or posing questions to the speaker.
At the end of this talk, participants will be able to: